142 related articles for article (PubMed ID: 26815588)
1. Morphine Attenuated the Cytotoxicity Induced by Arsenic Trioxide in H9c2 Cardiomyocytes.
Amini-Khoei H; Hosseini MJ; Momeny M; Rahimi-Balaei M; Amiri S; Haj-Mirzaian A; Khedri M; Jahanabadi S; Mohammadi-Asl A; Mehr SE; Dehpour AR
Biol Trace Elem Res; 2016 Sep; 173(1):132-9. PubMed ID: 26815588
[TBL] [Abstract][Full Text] [Related]
2. Characterization of cytotoxicity induced by arsenic trioxide (a potent anti-APL drug) in rat cardiac myocytes.
Raghu KG; Cherian OL
J Trace Elem Med Biol; 2009; 23(1):61-8. PubMed ID: 19203718
[TBL] [Abstract][Full Text] [Related]
3. Salvianolic Acid A Protects H9c2 Cells from Arsenic Trioxide-Induced Injury via Inhibition of the MAPK Signaling Pathway.
Zhang JY; Sun GB; Luo Y; Wang M; Wang W; Du YY; Yu YL; Sun XB
Cell Physiol Biochem; 2017; 41(5):1957-1969. PubMed ID: 28391263
[TBL] [Abstract][Full Text] [Related]
4. L-ascorbic acid and α-tocopherol attenuate arsenic trioxide-induced toxicity in H9c2 cardiomyocytes by the activation of Nrf2 and Bcl2 transcription factors.
Vineetha RC; Binu P; Arathi P; Nair RH
Toxicol Mech Methods; 2018 Jun; 28(5):353-360. PubMed ID: 29297235
[TBL] [Abstract][Full Text] [Related]
5. Polyphenol-rich apple (Malus domestica L.) peel extract attenuates arsenic trioxide induced cardiotoxicity in H9c2 cells via its antioxidant activity.
Vineetha VP; Girija S; Soumya RS; Raghu KG
Food Funct; 2014 Mar; 5(3):502-11. PubMed ID: 24441683
[TBL] [Abstract][Full Text] [Related]
6. Arsenic trioxide toxicity in H9c2 myoblasts--damage to cell organelles and possible amelioration with Boerhavia diffusa.
Vineetha VP; Prathapan A; Soumya RS; Raghu KG
Cardiovasc Toxicol; 2013 Jun; 13(2):123-37. PubMed ID: 23161055
[TBL] [Abstract][Full Text] [Related]
7. Azidothymidine hinders arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells by induction of p21 and attenuation of G2/M arrest.
Hassani S; Ghaffari SH; Zaker F; Mirzaee R; Mardani H; Bashash D; Zekri A; Yousefi M; Zaghal A; Alimoghaddam K; Ghavamzadeh A
Ann Hematol; 2013 Sep; 92(9):1207-20. PubMed ID: 23645216
[TBL] [Abstract][Full Text] [Related]
8. Rho-kinase inhibitor Y-27632 attenuates arsenic trioxide toxicity in H9c2 cardiomyoblastoma cells.
Bessho M; Aki T; Funakoshi T; Unuma K; Noritake K; Kato C; Uemura K
Cardiovasc Toxicol; 2013 Sep; 13(3):267-77. PubMed ID: 23532581
[TBL] [Abstract][Full Text] [Related]
9. Phloretin ameliorates arsenic trioxide induced mitochondrial dysfunction in H9c2 cardiomyoblasts mediated via alterations in membrane permeability and ETC complexes.
Vineetha VP; Soumya RS; Raghu KG
Eur J Pharmacol; 2015 May; 754():162-72. PubMed ID: 25746422
[TBL] [Abstract][Full Text] [Related]
10. Effect and mechanism of Sorbus pohuashanensis (Hante) Hedl. flavonoids protect against arsenic trioxide-induced cardiotoxicity.
Yu X; Wang Z; Shu Z; Li Z; Ning Y; Yun K; Bai H; Liu R; Liu W
Biomed Pharmacother; 2017 Apr; 88():1-10. PubMed ID: 28092839
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotective effect of salvianolic acid B against arsenic trioxide-induced injury in cardiac H9c2 cells via the PI3K/Akt signal pathway.
Wang M; Sun GB; Sun X; Wang HW; Meng XB; Qin M; Sun J; Luo Y; Sun XB
Toxicol Lett; 2013 Feb; 216(2-3):100-7. PubMed ID: 23201927
[TBL] [Abstract][Full Text] [Related]
12. Metallothionein prevention of arsenic trioxide-induced cardiac cell death is associated with its inhibition of mitogen-activated protein kinases activation in vitro and in vivo.
Miao X; Tang Z; Wang Y; Su G; Sun W; Wei W; Li W; Miao L; Cai L; Tan Y; Liu Q
Toxicol Lett; 2013 Jul; 220(3):277-85. PubMed ID: 23664956
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity of arsenic trioxide is enhanced by (-)-epigallocatechin-3-gallate via suppression of ferritin in cancer cells.
Lee TC; Cheng IC; Shue JJ; Wang TC
Toxicol Appl Pharmacol; 2011 Jan; 250(1):69-77. PubMed ID: 20950636
[TBL] [Abstract][Full Text] [Related]
14. Differential mechanistic investigation of protective effects from imperatorin and sec-O-glucosylhamaudol against arsenic trioxide-induced cytotoxicity in vitro.
Hu L; Sun J; Li H; Wang L; Wei Y; Wang Y; Zhu Y; Huo H; Tan Y
Toxicol In Vitro; 2016 Dec; 37():97-105. PubMed ID: 27608960
[TBL] [Abstract][Full Text] [Related]
15. Andrographolide protects against doxorubicin-and arsenic trioxide-induced toxicity in cardiomyocytes.
Safaeian L; Shafiee F; Haghighatnazar S
Mol Biol Rep; 2023 Jan; 50(1):389-397. PubMed ID: 36335523
[TBL] [Abstract][Full Text] [Related]
16. Arsenic Trioxide and Icariin Show Synergistic Anti-leukemic Activity.
Wang Z; Zhang H; Dai L; Song T; Li P; Liu Y; Wang L
Cell Biochem Biophys; 2015 Sep; 73(1):213-9. PubMed ID: 25721870
[TBL] [Abstract][Full Text] [Related]
17. Dithiothreitol abrogates the effect of arsenic trioxide on normal rat liver mitochondria and human hepatocellular carcinoma cells.
Paul MK; Kumar R; Mukhopadhyay AK
Toxicol Appl Pharmacol; 2008 Jan; 226(2):140-52. PubMed ID: 18022205
[TBL] [Abstract][Full Text] [Related]
18. Genistein selectively potentiates arsenic trioxide-induced apoptosis in human leukemia cells via reactive oxygen species generation and activation of reactive oxygen species-inducible protein kinases (p38-MAPK, AMPK).
Sánchez Y; Amrán D; Fernández C; de Blas E; Aller P
Int J Cancer; 2008 Sep; 123(5):1205-14. PubMed ID: 18546268
[TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide-induced apoptosis in H9c2 cardiomyocytes: implications in cardiotoxicity.
Zhao X; Feng T; Chen H; Shan H; Zhang Y; Lu Y; Yang B
Basic Clin Pharmacol Toxicol; 2008 May; 102(5):419-25. PubMed ID: 18346055
[TBL] [Abstract][Full Text] [Related]
20. Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells. Reactive oxygen species generation and defensive protein kinase (MEK/ERK, Akt/mTOR) modulation.
Calviño E; Estañ MC; Simón GP; Sancho P; Boyano-Adánez Mdel C; de Blas E; Bréard J; Aller P
Biochem Pharmacol; 2011 Dec; 82(11):1619-29. PubMed ID: 21889928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
